Antiphagocytic function of an IgG glycosyl hydrolase from Streptococcus equi subsp. equi and its use as a vaccine component

Infection and Immunity

Volumn 80, Issue 8, 2012, Pages 2914-2919

  Flock, Margareta ^a   Frykberg, Lars ^b   Sköld, Markus ^a   Guss, Bengt ^b   Flock, Jan Ingmar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOSE ENZYME; GLYCOSIDASE; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; OPSONIN; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; FEMALE; GLYCOSYLATION; IMMUNE EVASION; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOCOCCUS EQUI; STREPTOCOCCUS EQUI ZOOEPIDEMICUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; CLONING, MOLECULAR; FEMALE; FIBRONECTINS; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOSIDE HYDROLASES; IMMUNOGLOBULIN G; MICE; PHAGOCYTES; PROTEIN BINDING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS EQUI;

EID: 84864804883     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06083-11     Document Type: Article

References (22)

1. Albert H, Collin M, Dudziak D, Ravetch JV, Nimmerjahn F. 2008. In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner. Proc. Natl. Acad. Sci. U. S. A. 105: 15005-15009.
2. Allhorn M, et al. 2010. The IgG-specific endoglycosidase EndoS inhibits both cellular and complement-mediated autoimmune hemolysis. Blood 115: 5080-5088.
3. Allhorn M, Collin M. 2009. Sugar-free antibodies-the bacterial solution to autoimmunity? Ann. N. Y. Acad. Sci. 1173: 664-669.
4. Allhorn M, Olsen A, Collin M. 2008. EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity. BMC Microbiol. 8: 3.
5. Collin M, Olsen A. 2001. EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J. 20: 3046-3055.
6. Collin M, Shannon O, Bjorck L. 2008. IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions. Proc. Natl. Acad. Sci. U. S. A. 105: 4265-4270.
7. Collin M, et al. 2002. EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect. Immun. 70: 6646-6651.
8. Flock M, Karlstrom A, Lannergard J, Guss B, Flock JI. 2006. Protective effect of vaccination with recombinant proteins from Streptococcus equi subspecies equi in a strangles model in the mouse. Vaccine 24: 4144-4151.
9. Guss B, et al. 2009. Getting to grips with strangles: an effective multicomponent recombinant vaccine for the protection of horses from Streptococcus equi infection. PLoS Pathog. 5: e1000584. doi: 10.1371/journal.ppat.1000584.
10. Haggar A, Shannon O, Norrby-Teglund A, Flock JI. 2005. Dual effects of extracellular adherence protein from Staphylococcus aureus on peripheral blood mononuclear cells. J. Infect. Dis. 192: 210-217.
11. Harraghy N, et al. 2003. The adhesive and immunomodulating properties of the multifunctional Staphylocococcus aureus protein Eap. Microbiology 149: 2701-2707.
12. Harrington DJ, Sutcliffe IC, Chanter N. 2002. The molecular basis of Streptococcus equi infection and disease. Microbes Infect. 4: 501-510.
13. Holden MT, et al. 2009. Genomic evidence for the evolution of Streptococcus equi: host restriction, increased virulence, and genetic exchange with human pathogens. PLoS Pathog. 5: e1000346. doi: 10.1371/journal.ppat.1000346.
14. Hulting G, et al. 2009. Two novel IgG endopeptidases of Streptococcus equi. FEMS Microbiol. Lett. 298: 44-50.
15. Lannergard J, Guss B. 2006. IdeE, an IgG-endopeptidase of Streptococcus equi ssp. equi. FEMS Microbiol. Lett. 262: 230-235.
16. Nimmerjahn F, Ravetch JV. 2008. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8: 34-47.
17. Rennermalm A, et al. 2001. Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat. Vaccine 19: 3376-3383.
18. Rennermalm A, Nilsson M, Flock J-I. 2004. Fibrinogen binding protein (Fbe) of S. epidermidis is a target for opsonic antibodies. Infect. Immun. 72: 3081-3083.
19. Sweeney CR, Timoney JF, Newton JR, Hines MT. 2005. Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles. J. Vet. Intern. Med. 19: 123-134.
20. Timoney JF, Kumar P. 2008. Early pathogenesis of equine Streptococcus equi infection (strangles). Equine Vet. J. 40: 637-642.
21. Vernachio JH, et al. 2006. Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo. Antimicrob. Agents Chemother. 50: 511-518.
22. Yang R, et al. 2010. Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes. Nephrol. Dial. Transplant. 25: 2479-2486.